Receive the latest news
Stay in the loop!
Get notified about new articles
This brief covers two aligned opportunities: an immediate Regulatory Coordinator placement CORE has already sourced candidates for, and the strategic case for rebuilding Alliance's Manila QC team at scale. Both are ready to move.
CORE has pre-screened a shortlist of four candidates for the Regulatory Coordinator role Cheree has been prioritizing. Two are mid-level, two are senior. All have direct regulatory documentation and clinical trial experience. Alliance can review, select, and move to onboarding within 3 to 5 weeks from a go-decision.
Clinical Research Coordinator and CRA backgrounds with ICH-GCP certification, EDC platform experience (Medidata Rave, CRIO eReg), regulatory documentation, and TMF management. One carries a PhD in Genetics with direct US-based remote trial coordination experience at Arizona Liver Health. The other holds RN credentials with a PPD eTMF background spanning nearly four years.
Senior CRA and clinical operations leadership backgrounds with Phase II through III global trial experience, FDA inspection support with zero critical findings, risk-based monitoring, and CAPA governance. One carries 15-plus years across IQVIA, PPD, and ICON plc. The other has managed multi-country clinical operations at Fortrea, Novotech, and GlaxoSmithKline, and holds a pharmacy license.
Alliance's active QC job postings point to a pattern that most growing site networks eventually run into: the US clinical research labor market struggles to fill experienced QC roles fast enough, and even successful hires don't stay long. The combination of rapid site expansion and high onshore attrition creates a compounding capacity problem that traditional recruiting alone cannot solve.
The roles Alliance is advertising reflect demand that grows with each new office. Traditional recruiting timelines of 60 to 90 days per US hire cannot keep pace with that trajectory.
Experienced QC staff who leave take protocol familiarity and site-specific knowledge with them. Offshore teams managed by CORE average under 10% annual attrition — a structural advantage, not just a cost one.
Every site expansion adds document volume, query management, and phase-specific review load. A Manila team scales to each new office without triggering a new domestic recruiting cycle.
Add turnover risk and the cost compounds year over year. The offshore equivalent through CORE's managed services model runs $28K to $42K annually with all HR, compliance, and infrastructure included.
Alliance's expansion is following a durable industry trend. The context below matters for the Josh and Cheree discussion — and for what Anthony and Jason will ask when this goes up the org.
This is not a generalist offshore labor conversation. The Philippines has a broad, credentialed healthcare workforce spanning multiple licensed disciplines — RNs, pharmacists, medical technologists, biologists, clinical research coordinators, and pharmacovigilance specialists — actively placed in clinical research roles for US clients. For Alliance, that depth means CORE can staff across your QC function without compromising on credential level or clinical relevance.
Active Philippine nursing license. Clinical research background. ICH-GCP certified. Experienced with Medidata, Veeva Vault, and EDC platforms. Performs document-based QC review across trial records — source document verification, protocol adherence, data integrity, and regulatory compliance.
Philippine-licensed pharmacists with clinical research experience supporting investigational product accountability, drug dispensing documentation, protocol-defined dosing compliance, and pharmacy log maintenance. Particularly relevant for Phase I and II trials with complex IMP management requirements.
Licensed Philippine medical technologists supporting lab data review, specimen processing documentation, reference range validation, and central lab reconciliation. Strong familiarity with clinical laboratory standards and GCP-compliant data handling for trial endpoints.
Biology-degreed professionals supporting protocol review, scientific data abstraction, case narrative drafting, and literature-based background research. Useful for oncology, immunology, and biologics trials where scientific depth in document review adds material value to QC output.
Manages trial documentation workflows, tracks query resolution timelines, coordinates with site staff on outstanding items, and maintains TMF compliance and regulatory binders. Directly analogous to roles Alliance has previously used in the Manila team.
Supervises the Manila QC team, manages daily output against KPIs, serves as primary liaison with onshore QC management, and owns performance documentation. Reduces Josh's management overhead significantly as headcount scales.
Adverse event documentation, SAE reporting, safety database management, MedDRA coding under physician supervision. Philippine PV professionals are actively placed in US and global clinical research roles at scale.
CORE operates Alliance's team under a managed services model: all-in hourly rate, one vendor relationship. Alliance directs the work. CORE covers employment, HR, benefits, office, equipment, and Philippine statutory compliance. One rate. No hidden obligations on Alliance's books.
| Role | US Fully-Loaded Annual Cost | CORE Managed Services (Est. Annual) | Annual Savings Per Seat |
|---|---|---|---|
| Regulatory Coordinator (Mid) | $65,000 – $80,000 | $24,000 – $30,000 | ~$40,000 – $52,000 |
| Regulatory Coordinator (Senior) | $85,000 – $105,000 | $32,000 – $40,000 | ~$52,000 – $68,000 |
| QC Specialist (RN-Level) | $85,000 – $105,000 | $30,000 – $38,000 | ~$55,000 – $67,000 |
| QC Coordinator / Study Admin | $60,000 – $75,000 | $22,000 – $28,000 | ~$40,000 – $50,000 |
| Offshore QC Team Lead | $100,000 – $120,000 | $36,000 – $46,000 | ~$60,000 – $80,000 |
| Drug Safety / PV Associate | $70,000 – $90,000 | $26,000 – $34,000 | ~$44,000 – $60,000 |
At 35% annual turnover on a 15-person US QC team averaging $85K salary, Alliance absorbs $445,000 to $595,000 per year in turnover costs alone — before accounting for productivity loss during vacancy. The offshore model eliminates that exposure structurally, not just financially.
Alliance directs the work. CORE owns the employment relationship, the HR function, the physical office infrastructure, and all compliance obligations on the Philippines side.
CORE maintains active candidate pools for clinical research roles. We are not starting from zero. The timeline below reflects a typical engagement from initial scoping to go-live.
Define role profiles, phase requirements, volume targets, EDC systems, and documentation standards. Align on KPIs and the reporting structure between Manila and Alliance's US QC management team.
CORE presents pre-screened candidates with verified clinical research backgrounds. Alliance reviews and approves. No placement without your sign-off.
Team members complete your workflow training, EDC system orientation, and HIPAA compliance certification before handling live trial data. CORE manages the logistics. Alliance controls the content.
Manila QC team is operational and producing output against Alliance's KPIs. Initial performance review at 30 days. CORE manages ongoing HR, backfill, and compliance renewals from this point forward.
This brief covers both the immediate Regulatory Coordinator placement and the broader QC team rebuild. The agenda below is what we would like to cover on our call so we can focus the time on specifics rather than background.
Get notified about new articles